仁度生物：2025年第三季度归属于上市公司股东的净利润同比增长1361.80%

Core Insights - The company reported a revenue of 37,912,427.65 yuan for the third quarter of 2025, representing a year-on-year decline of 13.76% [2] - The net profit attributable to shareholders of the listed company was 4,975,755.59 yuan, showing a significant year-on-year increase of 1361.80% [2] Financial Performance - Revenue for Q3 2025: 37.91 million yuan, down 13.76% year-on-year [2] - Net profit for Q3 2025: 4.98 million yuan, up 1361.80% year-on-year [2]